JSE LIMITED - Dealings in securities by Directors, by the Company Secretary and by the JSE LTIS 2010 Trust

Dealings in securities by Directors, by the Company Secretary and by the JSE LTIS 2010 Trust

JSE Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2005/022939/06)
ISIN: ZAE000079711
Share Code: JSE
("JSE" or “the Company”)


DEALINGS IN SECURITIES BY DIRECTORS, BY THE COMPANY SECRETARY AND BY THE
JSE LTIS 2010 TRUST

In accordance with the terms of the JSE’s Long Term Incentive Scheme 2010
(“LTIS 2010”), a total of 445 830 JSE ordinary shares have been acquired
in the open market, on behalf of LTIS 2010 participants, to fulfil share
awards granted under LTIS 2010.

These ordinary shares are held in trust and are restricted until all
vesting conditions are fulfilled whereupon the shares vest.       To the
extent that the vesting conditions are not fulfilled the share awards are
forfeited.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2010 participant remaining in the employ of the JSE for the
     vesting term.

These JSE ordinary shares were acquired on-market, with clearance, at a
volume-weighted average price of R148.57 per ordinary share.   The high
and low prices for the various transactions were –



  Date in 2016
  that JSE             Number of JSE
  ordinary             ordinary
  shares               shares                       Daily high      Daily low
  acquired             acquired       Daily VWAP    price paid      price paid
                                                       

  26 February          20 859         135.28        134.50          136.20

  29 February          55 495         141.57        138.00          142.50

  1 March              82 848         145.98        142.35          147.00

  2 March              50 000         149.87        146.25          151.72

  3 March              55 000         149.96        149.40          151.50

  4 March              44 000         150.65        148.00          152.95

  7 March              80 000         153.45        152.51          154.53

  8 March              57 628         153.05        149.10          154.00



The individual allocations (grant and acceptance) were approved by the
JSE Board Human Resources, Social and Ethics Committee and clearance to
deal was granted by the Chairman of the Board.
At the Company’s annual general meeting held on 8 May 2014, shareholders
granted the following permissions in respect of the acquisition of JSE
ordinary shares:

(i)  Acquisition of JSE ordinary shares in the open market, granted in
     terms of special resolution #4 approved by the requisite majority of
     shareholders; and
(ii) Provision of specific financial assistance to the Trust for the
     purpose of acquiring the shares, granted in terms of special
     resolution #5 approved by the requisite majority of shareholders.


ALLOCATION OF SECURITIES TO DIRECTORS, THE COMPANY SECRETARY AND
PRESCRIBED OFFICERS

Members of the JSE’s executive committee, which includes the executive
directors and Company Secretary, have accepted grants of restricted
ordinary shares in the Company, as reflected in this announcement.

The vesting of these restricted JSE ordinary shares is subject to the
same vesting criteria as set out above.    For some executive committee
members (as indicated in the table below) a portion of their share award
is also subject to a separate restraint and retention agreement being
concluded with the JSE, in addition to meeting the corporate vesting
criteria.



                                       Number of
                              JSE ordinary shares awarded

                                             
                                             Corporate
                                             performance        Total value
                                             shares             of JSE
Executive                     Corporate      subject to         ordinary
Committee                     performance    additional         shares   
member          Role          shares         restraint &        awarded        Holding
                                             retention
                                             agreement
                                                  
                                             
                                                              
                                              
                 
                 CEO &                                                           Direct
NF Newton-King   Executive     41 240        NIL                6 127 027    beneficial
                 Director                                                    
                 
                 CFO &                                                           Direct
A Takoordeen     Executive     15 000        15 000             4 457 100    beneficial
                 Director                                                       
                 
JH Burke         Alternate     16 540        16 540             4 914 696        Direct
                 Director                                                    beneficial
                                                                   
                 Alternate                                                       Direct
LV Parsons       Director      17 790        17 790             5 286 121    beneficial
                                                                   
                 Prescribed                                                      Direct
A Greenwood      Officer       15 960        NIL                2 371 177    beneficial
                                                                    
                 Prescribed                                                      Direct
ZA Jacobs        Officer       14 320        14 320             4 255 045    beneficial
                                                                   
                 Prescribed                                                      Direct
D Oosthuyse      Officer       17 730        17 730             5 268 292    beneficial
                                                                   
                 Prescribed                                                      Direct
RJ van Wamelen   Officer       16 560        16 560             4 920 638    beneficial
                                                                  
                 Company                                                         Direct
GA Brookes       Secretary     12 390        12 390             3 681 565    beneficial
                                                                 
The corporate performance shares that are subject to a restraint and
retention agreement will vest on 1 March 2019, subject to the vesting
conditions being achieved.

The remaining corporate performance shares (not subject to a restraint
and retention agreement) will vest in two tranches, one-half on 1 March
2019 and the remaining half on 1 March 2020, subject to the vesting
conditions being achieved.

Individual share allocations have been accepted by the members of the
executive committee on 4 March 2016.


Sandton
10 March 2016


Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 10/03/2016 02:10:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.